Change of Date for Final Results
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces a revised date for the publication of its results for the year ended 30 April 2023.
The audit of the Group's Annual Report & Accounts is well advanced, however, the Group's auditor, BDO LLP, has requested more time to complete their standard audit. As a result, the Company will now announce its results on 24 October 2023, a delay to the previously planned date of 12 October 2023.
Professor Lindy Durrant, Chief Executive Officer, and Sath Nirmalananthan, Chief Financial Officer, will host an analyst briefing at 10:00am BST on the revised date of the results at the offices of ICR Consilium, 85 Gresham St, London, EC2V 7NQ.
The Company will also be holding a presentation for investors on 24 October 2023 at 4:30pm BST via the Investor Meet Company platform.
The presentation is open to all existing and potential shareholders and will be followed by a Q&A session. Questions can be submitted ahead of the event via the Investor Meet Company dashboard up until 9.00am BST on 23 October 2023, or at any time during the live presentation.
To sign up to Investor Meet Company for free and add to register for Scancell's presentation , please visit: https://www.investormeetcompany.com/scancell-holdings-plc/register-investor
A copy of the presentation will also be made available on the Company's news section following the presentation.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.